PhosLo

PhosLo (calcium acetate) is a new phosphate binder available for the prevention and management of hyperphosphataemia in patients with advanced renal failure on dialysis.

The usual starting dose is two capsules with each meal, increasing until the desired phosphate level is achieved; most patients will require three or four capsules with each meal to achieve adequate control of phosphate levels.

View PhosLo drug record

Further information: Fresenius

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Soft-mist inhaler now available as reusable device

Soft-mist inhaler now available as reusable device

Respimat is now available as a reusable inhaler that...

NICE recommends 'innovative' treatment for type I diabetes

NICE recommends 'innovative' treatment for type I diabetes

Dapagliflozin (Forxiga) has been approved for routine...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Elleste Duet, Elleste Solo, Diprosone and Livial.

Potentially addictive medicines 'being prescribed for years'

Potentially addictive medicines 'being prescribed for years'

Hundreds of thousands of people are receiving prescriptions...